12
Participants
Start Date
August 24, 2023
Primary Completion Date
June 30, 2025
Study Completion Date
December 31, 2025
EU307 CAR-T Cell
"* Dose to be administered: a single dose~* IV administration~* Dosing rate: To be administrated at a rate of approximately 2 mL/min"
RECRUITING
National Cancer Center, Gyeonggi-do
RECRUITING
Severance Hospital, Seoul
RECRUITING
SoonChunHyang University Hospital Seoul, Seoul
RECRUITING
The Catholic University of Korea Seoul ST.MARY'S Hospital., Seoul
Lead Sponsor
Eutilex
INDUSTRY